Pharmacokinetics of Miltefosine in Children and Adults with Cutaneous Leishmaniasis.
Castro, María Del Mar; Gomez, Maria Adelaida; Kip, Anke E; Cossio, Alexandra; Ortiz, Eduardo; Navas, Adriana; Dorlo, Thomas P C; Saravia, Nancy Gore.
Antimicrob Agents Chemother
; 61(3)2017 03.
Artigo em Inglês | MEDLINE | ID: mdl-27956421
Anti-leishmanial effect of spiro dihydroquinoline-oxindoles on volume regulation decrease and sterol biosynthesis of Leishmania braziliensis.
Efficacy of tamoxifen and miltefosine combined therapy for cutaneous leishmaniasis in the murine model of infection with Leishmania amazonensis.
Combined suboptimal schedules of topical paromomycin, meglumine antimoniate and miltefosine to treat experimental infection caused by Leishmania (Viannia) braziliensis.
Two cases of cutaneous leishmaniasis in Dutch military personnel treated with oral miltefosine.
In Vitro Sensitivity of Cutaneous <i>Leishmania</i> Promastigote Isolates Circulating in French Guiana to a Set of Drugs.
Efficacy and safety of miltefosine in treatment of post-kala-azar dermal leishmaniasis.
In vitro activity of new N-benzyl-1H-benzimidazol-2-amine derivatives against cutaneous, mucocutaneous and visceral Leishmania species.
Monitoring the response of patients with cutaneous leishmaniasis to treatment with pentamidine isethionate by quantitative real-time PCR, and identification of Leishmania parasites not responding to therapy.
Post-kala-azar dermal leishmaniasis with mucosal involvement: an unusual case presentation including successful treatment with miltefosine.
Zosteriform cutaneous leishmaniasis due to Leishmania ( Viannia ) panamensis and Leishmania ( Viannia ) braziliensis: report of three cases.